Anti-CDKN2A/p16INK4a antibody [2D9A12]
4
(20 Reviews)
|
(191 Publications)
Anti-CDKN2A/p16INK4a antibody [2D9A12] (ab54210) is a mouse monoclonal antibody detecting CDKN2A/p16INK4a in Flow Cytometry, IHC-P. Suitable for Human, Rat.
- Over 140 publications
- Trusted since 2007
View Alternative Names
CDKN2, MTS1, CDKN2A, Cyclin-dependent kinase inhibitor 2A, Cyclin-dependent kinase 4 inhibitor A, Multiple tumor suppressor 1, p16-INK4a, CDK4I, MTS-1, p16-INK4, p16INK4A
- IHC-P
AbReview12857****
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CDKN2A/p16INK4a antibody [2D9A12] (AB54210)
ab54210 staining CDKN2A/p16INK4a in human cervix and ovarian carcinoma tissue sections by Immunohistochemistry (IHC-P - paraformaldehyde-fixed, paraffin-embedded sections).
Tissue was fixed with formaldehyde and antigen retrieval was by heat mediation in a citrate buffer. Samples were incubated with primary antibody (1/4000) for 20 minutes at 25°C. An undiluted HRP-conjugated mouse polymer was used as the secondary antibody.
Image is courtesy of an anonymous AbReview
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CDKN2A/p16INK4a antibody [2D9A12] (AB54210)
ab54210 at a 1 : 500 staining CDKN2A/p16INK4a in human brain tissue by immunohistochemistry using paraffin embedded tissue. Nuclear staining (DAB staining) is shown.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CDKN2A/p16INK4a antibody [2D9A12] (AB54210)
ab54210 at a 1 : 500 staining CDKN2A/p16INK4a in human brain tumor tissue by immunohistochemistry using paraffin embedded tissue. Nuclear staining (DAB) is shown.
- IHC-P
AbReview63857****
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CDKN2A/p16INK4a antibody [2D9A12] (AB54210)
Zinc buffered formalin-fixed human cartilage tissue stained for CDKN2A/p16INK4a using ab54210 at a 1/200 dilution for 15 hours at 4°C. A Goat-anti-mouse polyclonal-biotin was used at the secondary at a 1/200 dilution. For further detail please see abreview.
Image is courtesy of an anonymous abreview by a verified customer
- Flow Cyt
Unknown
Flow Cytometry - Anti-CDKN2A/p16INK4a antibody [2D9A12] (AB54210)
Overlay histogram showing HeLa (Human epithelial cell line from cervix adenocarcinoma) cells stained with ab54210 (red line).
The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab54210, 1/50 dilution) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG2b [PLPV219] (ab91366, 2μg/1x106 cells) used under the same conditions.
Acquisition of >5,000 events was performed.
This antibody gave a positive signal in HeLa cells fixed with 4% paraformaldehyde/permeabilized in 0.1% PBS-Tween used under the same conditions.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CDKN2A/p16INK4a antibody [2D9A12] (AB54210)
ab54210 at a 1 : 500 staining CDKN2A/p16INK4a in rat liver tissue by immunohistochemistry using paraffin embedded tissue. Nuclear staining (DAB staining) is shown.
- IHC-P
AbReview67297****
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CDKN2A/p16INK4a antibody [2D9A12] (AB54210)
10% formalin-fixed rat kidney tissue stained for CDKN2A/p16INK4a using ab54210 at a 1/500 dilution for 16 hours at 4°C. A Cy3-conjugated donkey-anti-mouse was used at the secondary at a 1/200 dilution. For further detail please see abreview.
Image is courtesy of an anonymous abreview by a verified customer
- IHC-P
AbReview17273****
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CDKN2A/p16INK4a antibody [2D9A12] (AB54210)
ab54210 staining CDKN2A/p16INK4a in human skin tissue sections by Immunohistochemistry (IHC-P - paraformaldehyde-fixed, paraffin-embedded sections).
Tissue was fixed with formaldehyde and blocked with 2% BSA for 1 hour at 22°C; antigen retrieval was by heat mediation in a citrate buffer. Samples were incubated with primary antibody (1/100 in 1% NGS/TBS) for 20 hours at 4°C. ab6785 (1/800) was used as the secondary antibody.
Image courtesy of an anonymous AbReview
Reactivity data
Product details
Anti-CDKN2A/p16INK4a antibody [2D9A12] (ab54210) is a mouse monoclonal antibody and is validated for use in Flow Cyt, IHC-P in human, rat samples.
Anti-CDKN2A/p16INK4a antibody [2D9A12] (ab54210) specifically detects CDKN2A/p16INK4a (UniProt ID: P42771; Molecular weight: 17kDa) and is sold in 100 µL selling sizes.
Quality and Validation
Abcam's high quality validation processes ensure Anti-CDKN2A/p16INK4a antibody [2D9A12] (ab54210) has high sensitivity and specificity.
Anti-CDKN2A/p16INK4a antibody [2D9A12] (ab54210) has been cited over 142 times in peer reviewed journals and is trusted by the scientific community.
Anti-CDKN2A/p16INK4a antibody [2D9A12] (ab54210) has 18 independent reviews from customers.
Target Information
CDKN2A, also known as cyclin-dependent kinase inhibitor 2A, is a crucial tumor suppressor gene located on chromosome 9p211. It encodes two proteins, p16INK4a and p14ARF, both of which play significant roles in regulating the cell cycle. p16INK4a inhibits cyclin-dependent kinases 4 and 6 (CDK4 and CDK6), preventing the progression from the G1 to S phase of the cell cycle. This inhibition is vital for controlling cell proliferation and preventing tumor growth. Mutations or deletions in CDKN2A are frequently associated with various cancers, including melanoma, pancreatic cancer, and head and neck squamous cell carcinoma.
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (191)
Recent publications for all applications. Explore the full list and refine your search
Stem cell research & therapy 16:526 PubMed41024282
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:8477 PubMed41006208
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 29:e70800 PubMed40845179
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature aging 5:1046-1062 PubMed40495018
2025
Applications
Unspecified application
Species
Unspecified reactive species
Redox report : communications in free radical research 30:2511458 PubMed40489575
2025
Applications
Unspecified application
Species
Unspecified reactive species
Stem cell research & therapy 16:231 PubMed40346705
2025
Applications
Unspecified application
Species
Unspecified reactive species
Gut 74:1828-1846 PubMed40335161
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of neuroinflammation 22:101 PubMed40197319
2025
Applications
Unspecified application
Species
Unspecified reactive species
Redox biology 82:103606 PubMed40158257
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:2283 PubMed40055369
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com